Actionnariat et activité des initiés pour IN8bio, Inc. (INAB): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $1.01 |
| Capitalisation | $10M |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-05-27 | FAIRBAIRN EMILY | G-Gift | 724,637 | |
| 2026-05-09 | Ho William Tai-Wei | A-Award | 154,500 | $244K |
| 2026-05-09 | Greenwood Luba | A-Award | 22,000 | $35K |
| 2026-05-09 | Lamb Lawrence | A-Award | 54,000 | $85K |
| 2026-05-09 | FAIRBAIRN EMILY | A-Award | 22,000 | $35K |
| 2026-05-09 | McCall Patrick | A-Award | 56,250 | $89K |
| 2026-05-09 | Rochlin Kate | A-Award | 60,000 | $95K |
| 2026-05-09 | Epperly Corinne | A-Award | 22,000 | $35K |
| 2026-05-09 | Brandt Peter C. | A-Award | 22,000 | $35K |
| 2026-05-09 | Graff Jeremy R. | A-Award | 22,000 | $35K |
Bilan (10 ans)
| Année | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Trésorerie | $5.0M | $610000 | $18.0M | $37.0M | $18.2M | $21.3M | $11.1M | $27.1M |
| Placements à Court Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Créances | $30000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stocks | $15000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Courants | $5.1M | $763000 | $18.1M | $39.0M | $22.2M | $24.6M | $12.6M | $27.9M |
| Immobilisations Corporelles | $795000 | $274000 | $186000 | $2.8M | $10.3M | $8.6M | $7.8M | $4.0M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | 0 | 0 | 0 | 0 | $126000 | 0 | 0 | 0 |
| Actifs Totaux | $5.9M | $1.1M | $20.9M | $42.2M | $33.0M | $33.7M | $20.9M | $32.3M |
| Dettes Fournisseurs | $419000 | $560000 | $620000 | $395000 | $2.1M | $924000 | $389000 | $309000 |
| Dette à Court Terme | 0 | 0 | $174000 | 0 | 0 | 0 | 0 | 0 |
| Passifs Courants | $419000 | $647000 | $2.6M | $2.3M | $5.8M | $5.4M | $3.1M | $3.2M |
| Dette à Long Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $1.6M |
| Passifs Totaux | $1.2M | $1.5M | $2.6M | $4.0M | $10.3M | $8.8M | $6.5M | $4.7M |
| Réserves | -$4.3M | -$9.5M | -$18.0M | -$32.7M | -$61.2M | -$91.2M | -$121.7M | -$141.1M |
| Capitaux Propres | $4.6M | -$346000 | $18.3M | $38.2M | $22.7M | $24.9M | $14.5M | $27.6M |
| Dette Totale | 0 | 0 | $174000 | $2.4M | $5.9M | $4.9M | $5.0M | $2.8M |
| Dette Nette | -$5.0M | -$610000 | -$17.8M | -$34.6M | -$12.3M | -$16.4M | -$6.1M | -$24.3M |
| Fonds de Roulement | $4.7M | $116000 | $15.6M | $36.7M | $16.4M | $19.2M | $9.5M | $24.7M |
Entreprises liées: ACXP · APRE · APVO · BCDA · GLTO · HCWB · KPRX
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de INAB: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions